Some studies indicate that anti-VEGF/VEGFR agents appeared to inhibit the growth of endometriosis, with no effect on ovarian function, and therefore anti-angiogenic therapy may become a future strategy in treating endometriosis [8]. Here, VEGFA is linked to endometriosis.